ZW7583A1 - Products and methods for treatment of cancer - Google Patents

Products and methods for treatment of cancer

Info

Publication number
ZW7583A1
ZW7583A1 ZW75/83A ZW7583A ZW7583A1 ZW 7583 A1 ZW7583 A1 ZW 7583A1 ZW 75/83 A ZW75/83 A ZW 75/83A ZW 7583 A ZW7583 A ZW 7583A ZW 7583 A1 ZW7583 A1 ZW 7583A1
Authority
ZW
Zimbabwe
Prior art keywords
cancer
products
treatment
methods
Prior art date
Application number
ZW75/83A
Other languages
English (en)
Inventor
David Stephen Terman
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of ZW7583A1 publication Critical patent/ZW7583A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZW75/83A 1982-04-07 1983-03-25 Products and methods for treatment of cancer ZW7583A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (1)

Publication Number Publication Date
ZW7583A1 true ZW7583A1 (en) 1983-06-29

Family

ID=27003359

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW75/83A ZW7583A1 (en) 1982-04-07 1983-03-25 Products and methods for treatment of cancer

Country Status (13)

Country Link
EP (1) EP0091784B1 (de)
AU (2) AU569467B2 (de)
CA (1) CA1230555A (de)
DE (1) DE3374756D1 (de)
DK (1) DK154283A (de)
ES (5) ES521279A0 (de)
FI (1) FI831169L (de)
GB (2) GB2119803B (de)
GR (1) GR78514B (de)
NO (5) NO831223L (de)
PT (1) PT76505B (de)
RO (3) RO86661A (de)
ZW (1) ZW7583A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
EP0694066A4 (de) * 1993-04-08 1997-01-29 Univ Texas Modell für die gonokokkeninfektion
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
MX2011012094A (es) * 2009-05-14 2012-03-26 Oatmeal Biotechnologies Group L L C Tecnologias de plataforma para enfermedades que se presentan espontaneamente.
EP3426265B1 (de) 2016-04-28 2021-09-22 Alkahest, Inc. Plasmafraktionen als therapie von tumorwachstum und -progression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
FI791551A (fi) * 1978-05-17 1979-11-18 Benzon As Alfred Renad cancer associerad protein

Also Published As

Publication number Publication date
GB2163164B (en) 1986-09-03
NO841497L (no) 1983-10-10
NO831223L (no) 1983-10-10
ES8405621A1 (es) 1984-06-16
ES528119A0 (es) 1985-04-16
GR78514B (de) 1984-09-27
PT76505A (en) 1983-05-01
RO89498A (ro) 1986-06-30
ES521279A0 (es) 1984-06-16
ES528118A0 (es) 1985-04-16
FI831169L (fi) 1983-10-08
GB2163164A (en) 1986-02-19
GB2119803A (en) 1983-11-23
NO841498L (no) 1983-10-10
RO86661A (ro) 1986-07-30
GB8510892D0 (en) 1985-06-05
ES528120A0 (es) 1985-04-16
NO841495L (no) 1983-10-10
CA1230555A (en) 1987-12-22
NO841496L (no) 1983-10-10
EP0091784A2 (de) 1983-10-19
EP0091784A3 (en) 1984-07-11
FI831169A0 (fi) 1983-04-06
DK154283D0 (da) 1983-04-07
ES8503950A1 (es) 1985-04-16
GB8309348D0 (en) 1983-05-11
AU1286583A (en) 1983-10-13
ES528121A0 (es) 1985-11-01
AU569467B2 (en) 1988-02-04
ES8503954A1 (es) 1985-04-16
RO86661B (ro) 1985-03-01
ES8503953A1 (es) 1985-04-16
RO89496A (ro) 1986-06-30
PT76505B (en) 1986-05-05
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
DK154283A (da) 1983-10-08
AU1560088A (en) 1988-10-27
DE3374756D1 (en) 1988-01-14
EP0091784B1 (de) 1987-12-02

Similar Documents

Publication Publication Date Title
NZ204298A (en) Refined detoxified endotoxin product and cancer treatment
GB2116036B (en) Treatment of acne
GB2173787B (en) Derivatives of cycloalkanols and cycloalkenols
GB8322218D0 (en) Treatment of cancers
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
IL76071A0 (en) Method and composition for treatment of cancer
GB8315577D0 (en) Air treatment of products
PT83407A (en) Water treatment method and product
GB2098850B (en) Treatment of vegetables
MTP924B (en) Homogenous human immune interferom and process therefor
DE3360650D1 (en) Process for the preparation of o-toluidin and/or m-toluidin and/or p-toluidin
GB8319365D0 (en) Treatment of metals
DE3378543D1 (en) Apparatus and method for the treatment of food with microwaves
GB8321131D0 (en) Treatment of meat
ZW7583A1 (en) Products and methods for treatment of cancer
GB8314202D0 (en) Treatment of stainless steel apparatus
GB2120247B (en) Substituted iminoderivatives of dihydrobenzo-pyran and dihydrobenzothiopyran and process for their preparation
PH17865A (en) Method of treatment
GB2122897B (en) Treatment of cancer with microorganisms obtained products
GB8313888D0 (en) Surface treatment of products
JPS5781804A (en) Improvement of treatment of substance
GB2117647B (en) Medical treatment and apparatus therefor
DE3363428D1 (en) Method of treating flaxen
IE830799L (en) Products and methods for treatment of cancer
DE3372904D1 (en) Method and device for the treatment of allergy causing products and objects